These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Modeling of substrate specificity of the Alzheimer's disease amyloid precursor protein beta-secretase. Sauder JM; Arthur JW; Dunbrack RL J Mol Biol; 2000 Jul; 300(2):241-8. PubMed ID: 10873463 [TBL] [Abstract][Full Text] [Related]
8. Cysteine proteases are the major beta-secretase in the regulated secretory pathway that provides most of the beta-amyloid in Alzheimer's disease: role of BACE 1 in the constitutive secretory pathway. Hook VY; Reisine TD J Neurosci Res; 2003 Nov; 74(3):393-405. PubMed ID: 14598316 [TBL] [Abstract][Full Text] [Related]
9. The proteins BACE1 and BACE2 and beta-secretase activity in normal and Alzheimer's disease brain. Stockley JH; O'Neill C Biochem Soc Trans; 2007 Jun; 35(Pt 3):574-6. PubMed ID: 17511655 [TBL] [Abstract][Full Text] [Related]
10. BACE: Therapeutic target and potential biomarker for Alzheimer's disease. Evin G; Barakat A; Masters CL Int J Biochem Cell Biol; 2010 Dec; 42(12):1923-6. PubMed ID: 20817005 [TBL] [Abstract][Full Text] [Related]
11. Promising anti-Alzheimer's dimer bis(7)-tacrine reduces beta-amyloid generation by directly inhibiting BACE-1 activity. Fu H; Li W; Luo J; Lee NT; Li M; Tsim KW; Pang Y; Youdim MB; Han Y Biochem Biophys Res Commun; 2008 Feb; 366(3):631-6. PubMed ID: 18039469 [TBL] [Abstract][Full Text] [Related]
12. Characterization of Abeta11-40/42 peptide deposition in Alzheimer's disease and young Down's syndrome brains: implication of N-terminally truncated Abeta species in the pathogenesis of Alzheimer's disease. Liu K; Solano I; Mann D; Lemere C; Mercken M; Trojanowski JQ; Lee VM Acta Neuropathol; 2006 Aug; 112(2):163-74. PubMed ID: 16865398 [TBL] [Abstract][Full Text] [Related]
13. Caspase-3 cleavage of GGA3 stabilizes BACE: implications for Alzheimer's disease. Vassar R Neuron; 2007 Jun; 54(5):671-3. PubMed ID: 17553417 [TBL] [Abstract][Full Text] [Related]
14. Amyloid-beta, BACE, and oxidative stress in Alzheimer's disease, a commentary on "The different aggregation state of beta-amyloid 1-42 mediates different effects on oxidative stress, neurodegeneration and BACE-1 expression". Lee HG; Perry G; Zhu X; Nunomura A; Smith MA Free Radic Biol Med; 2006 Jul; 41(2):188-9. PubMed ID: 16814097 [No Abstract] [Full Text] [Related]
16. Β-site APP-cleaving enzyme 1 trafficking and Alzheimer's disease pathogenesis. Tan J; Evin G J Neurochem; 2012 Mar; 120(6):869-80. PubMed ID: 22171895 [TBL] [Abstract][Full Text] [Related]
17. Progress toward the discovery and development of efficacious BACE inhibitors. Durham TB; Shepherd TA Curr Opin Drug Discov Devel; 2006 Nov; 9(6):776-91. PubMed ID: 17117686 [TBL] [Abstract][Full Text] [Related]
18. Demonstration by FRET of BACE interaction with the amyloid precursor protein at the cell surface and in early endosomes. Kinoshita A; Fukumoto H; Shah T; Whelan CM; Irizarry MC; Hyman BT J Cell Sci; 2003 Aug; 116(Pt 16):3339-46. PubMed ID: 12829747 [TBL] [Abstract][Full Text] [Related]
19. Decreased expression of GGA3 protein in Alzheimer's disease frontal cortex and increased co-distribution of BACE with the amyloid precursor protein. Santosa C; Rasche S; Barakat A; Bellingham SA; Ho M; Tan J; Hill AF; Masters CL; McLean C; Evin G Neurobiol Dis; 2011 Jul; 43(1):176-83. PubMed ID: 21440067 [TBL] [Abstract][Full Text] [Related]